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Abstract
Background—A comprehensive understanding of the etiology and neurobiology of nicotine
dependence is not available. We sought to identify genomic regions that might contain etiologically-
relevant loci using genomewide univariate and bivariate linkage analyses.
Methods—We conducted secondary data analyses of 626 all possible sibling pairs ascertained in
Ireland and Northern Ireland on the basis of alcohol dependence. A set of 1,020 short tandem repeat
genetic markers were genotyped in all subjects. The phenotypes analyzed were the Fagerström Test
for Nicotine Dependence (FTND), a history of nicotine dependence, the number of symptoms of
alcohol dependence (AlcSx), and a history of alcohol dependence. Genomewide linkage analyses
were conducted with non-parametric and variance components methods.
Findings—For the bivariate variance component analysis of the continuous FTND and AlcSx
scores, multipoint LOD scores were >4 in two genomic regions – an 11 cM region on chr7 (D7S2252
to D7S691, empirical p=0.0006) and an 8 cM region on chr18 flanking D18S63 (empirical p=0.0007).
These findings did not exceed a conservative estimate of study-wide significance. The remaining
sets of findings had considerably smaller or less consistent peak signals. Notably, strong linkage
signal at D4S1611 for AlcSx from a prior report (PMID 16534506) was not found when jointly
analyzed with FTND.
Interpretation—Replication is required. However, chromosomes 7 and 18 may contain genetic
loci relevant to the etiology of nicotine-related phenotypes.
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Cigarette smoking is a first-rank public health problem (US Department of Health and Human
Services, 1989; Centers for Disease Control, 1994b; World Health Organization, 1997).
Although the prevalence of cigarette use in the US and so-called “first-world” countries has
declined dramatically since 1964 (US Department of Health and Human Services, 1964), there
remains a core group of smokers who rarely achieve sustained cessation (Glasgow and Orleans,
1997) despite often evidencing both the desire to quit (Centers for Disease Control, 1994a) and
making serious attempts at cessation (US Department of Health and Human Services, 1989;
US Department of Health and Human Services, 1990). In many other countries, the prevalence
of smoking is rising alarmingly (World Health Organization, 2006).
One line of inquiry into developing new methods for understanding and treating nicotine
dependence is to adapt approaches commonly used for elucidating the genetic basis of other
complex human traits of biomedical importance (e.g., genomewide linkage and association
studies). The rationale for these approaches are elucidated at length elsewhere – briefly, these
studies are predicated on observations that various smoking behaviors are heritable,
particularly the core phenotype of nicotine dependence (Sullivan and Kendler, 1999; Li et al.,
2003a). For example, a detailed analysis of the literature estimated the heritability in liability
of nicotine dependence (or its proxies) to be 0.67 with the remaining variance from shared
environmental (0.02) and individual-specific environmental effects (0.31) (Sullivan and
Kendler, 1999).
We are aware of eleven published genomewide linkage studies of smoking-related phenotypes
from seven independent samples. One sample was ascertained on the basis of smoking behavior
(Straub et al., 1999; Sullivan et al., 2004). Four samples informative for smoking behavior
were created from population-based parent studies in Framingham, MA (Goode et al., 2003;
Li et al., 2003b; Wang et al., 2005), Mission Indians near San Diego, CA (Ehlers and
Wilhelmsen, 2006), a longitudinal study in California (Swan et al., In press), and the Australian
Twin Registry (Morley et al., 2005). The remaining studies were all from secondary data
analyses of samples ascertained on the basis of alcohol dependence (as with this report) (Bergen
et al., 1999; Duggirala et al., 1999; Bierut et al., 2004) or panic disorder (Gelernter et al.,
2004). The autosomal findings from these studies are depicted in Figure 1. A few genomic
regions overlap but the extant data are not strikingly consistent.
Our goal in this report was to attempt to add meaningfully to this literature by conducting a
secondary data analysis of genomewide linkage data for nicotine dependence-related
phenotypes in a large sample genotyped with a relatively large number of microsatellite
markers. Ascertainment and primary genome scan analyses focused on alcohol dependence
(Prescott et al., 2005; Prescott et al., 2006); however, given data suggesting a significant and
perhaps sizeable genetic correlations between alcohol and nicotine dependence (Hettema et
al., 1999; True et al., 1999), we reasoned that analyses of this sample would also be informative
for nicotine dependence. There were two primary goals. First, we sought to generate new
hypotheses about the location of genes that influence liability to pathological alcohol and
nicotine use. Second, we wished to see if a striking previous finding from this sample for the
number of alcohol symptoms (peak multipoint LOD 4.59 at D4S1611, p=0.0000021) (Prescott
et al., 2006) was alcohol-specific or shared in some manner with nicotine dependence.
2. Methods
2.1
Clinical data collection occurred between 1998−2002 as a joint collaboration among Virginia
Commonwealth University, the Health Research Board in Dublin, and Shaftsbury Square
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Hospital in Belfast (Prescott et al., 2005; Prescott et al., 2006). All interviewed participants
provided informed consent prior to assessment and sample collection. The study protocol and
consent procedures were approved by the VCU Institutional Review Board, Western IRB, the
Health Research Board of the Irish Republic, and the human subjects committees of the
treatment facilities from which participants were recruited (where such committees existed).
Proband ascertainment was by convenience sampling centered on community alcoholism
treatment facilities and public and private hospitals in the Republic of Ireland and Northern
Ireland. Probands were eligible for inclusion if they met DSM-IV criteria for alcohol
dependence (American Psychiatric Association, 1994) and if all four grandparents had been
born in Ireland, Northern Ireland, Scotland, Wales, or England. In addition, the proband was
required to have at least one full sibling who met the same inclusion criteria. Individuals with
other substance dependence and psychiatric disorders were not excluded but we did assess the
chronological relationship between the onsets of these disorders and alcohol dependence. We
attempted to enroll all living biological parents for whom the probands provided permission
to contact.
Probands, siblings and parents were interviewed by clinically-trained research interviewers
(often with extensive clinical experience with alcoholism) usually in participants' homes or a
treatment facility. A small proportion of siblings who lived outside Ireland were interviewed
by telephone. The symptoms of nicotine dependence (during the period of lifetime maximum
tobacco use) were assessed with an adapted version (Kendler et al., 1999) of the Fagerström
Test for Nicotine Dependence (FTND) (Heatherton et al., 1991). A history of nicotine
dependence (ND) was considered present if the subject had an FTND score ≥7 (Kendler et al.,
1999). The phenotypic status of individuals who had never smoked was considered as
unknown. DSM-IV alcohol dependence (AD) and the number of symptoms of alcohol
dependence (AlcSx, based on the DSM-IV alcohol dependence criteria, range 3−7) during a
subject's lifetime period of heaviest use were assessed with the SSAGA interview (version 11)
(Bucholz et al., 1994). I
2.2
Laboratory Methods are described in detail elsewhere (Prescott et al., Submitted). Genotyping
was blinded to all phenotypic data. Briefly, an autosomal genomewide screen was conducted
by deCODE Genetics (http://www.decode.com) using a panel of 1,020 microsatellite markers
(average spacing of 4 cM) with an average heterozygosity of 0.725 (range 0.063−0.918) as
calculated from our linkage sample using PEDSTATS (Wigginton and Abecasis, 2005). Based
on 17 duplicated samples, between-sample agreement averaged 99.68% (range 98.44%
−100%).
Full details of the data cleaning process is provided in (Prescott et al., 2006). Briefly, data
cleaning was accomplished using GRR (Abecasis et al., 2001) and Merlin (Abecasis et al.,
2002). After data cleaning, 1,289 samples were included in the linkage analyses reported here
− 470 families (2−12 members) with 81.1%, 14.2%, and 1.9% containing 2, 3, or 4 persons.
There were 626 all possible sibling pairs.
2.3 Statistical Analyses
Univariate singlepoint and multipoint linkage analyses were performed using Merlin (Abecasis
et al., 2002). Singlepoint analysis uses linkage information from each marker independently
whereas multipoint analysis incorporates linkage information from nearby markers. Marker
allele frequencies were estimated from 66 blood bank volunteers from Ireland and Northern
Ireland. For ND, we used non-parametric linkage and we report the NPL-LOD and asymptotic
p-values generated by Merlin. For FTND symptom counts, we used Merlin-Regress. This
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method can be applied to selected samples but requires specification of the trait distribution
parameters in the general population. We used the trait distribution (mean=4.32 and
variance=7.24) from Virginia adult twin samples and weighted the gender ratio according to
that of the present sample.
Bivariate linkage analyses (adjusted for sex and age) were conducted for both binary (ND-AD)
and ordinal traits (FTND score-AlcSx) using Mx (Neale et al., 2004). Due to computational
constraints, we only conducted multipoint analyses. Variance components linkage analyses
were applied in the models that partitioned the covariation of the two traits into QTL effects,
familial effects (residual additive genetic and shared environment), and residual effects (non-
shared environment and measurement error). We assumed the underlying liability of the two
traits was bivariate normal and a maximum likelihood method was used for parameter
estimation. Differences between log likelihood ratios of models with and without QTL effects
were used to estimate the 2 df bivariate LOD scores. We transformed these scores to make
them comparable to the 1 df univariate LOD score, and obtained the corresponding p-value
based on the asymptotic mixture distributions of , , and  under the null hypothesis of
no linkage for either trait (Self and Liang, 1987). Empirical p-values for linkage peaks were
obtained by permutation for the four principal linkage peaks (due to computational limitations)
(North et al., 2002). Bivariate analyses were also corrected for the ascertainment bias inherent
in selecting on the lifetime presence of AD. Not performing such a correction would tend to
underestimate the covariation between the two traits. Correction for ascertainment bias requires
population data on the probability of AD; as these epidemiological data were not available for
Ireland, we used US lifetime prevalence estimates of 20.2% for males and 8.2% for females
(Kessler et al., 1994). However, the use of US data are qualified by the known differences in
yearly per capita alcohol consumption (US 8.51 liters, UK 10.4 liters, and Ireland 14.5 liters)
(World Health Organization, 2004).
The study-wide significance level is set to be 1×10−5, approximately the results of dividing
0.05 by the number or markers (1,020) times the number of statistical tests (4). This is quite
conservative as no account is made for correlations among markers due to linkage
disequilibrium and covariation among the phenotypes studied. Empirical “gene-dropping”
estimations were not practical due to computing constraints.
3. Results
For the subjects included in these analyses (N=1,289), the mean age was 41.9 years (SD 9.7),
64.3% were male, nearly all met criteria for lifetime AD (there were seven subjects who barely
missed meeting criteria for AD), and 61.9% met criteria for ND. The median FTND score was
7 with an interquartile range of 5−9. The median AlcSx count was 7 with an interquartile range
of 6−7. There was a significant albeit modest phenotypic correlation between FTND and AlcSx
(Spearman ρ=0.15, p<0.0001). In a phenotypic multivariate model, the FTND score during the
lifetime period of maximal smoking was significantly predicted by younger age at interview
(p=0.02), greater AlcSx (p=0.003), and the sex × AlcSx interaction (p=0.03, at comparable
levels of AlcSx, males have higher FTND scores than women). Additional information about
this sample is presented elsewhere (Prescott et al., 2005).
Figure 1 shows the four sets of linkage results for this investigation. For all four sets of analyses,
lines plot the multipoint results. Multipoint linkage analyses should generally provide the most
powerful analyses of the linkage data as they maximize the use of information from each marker
plus nearby markers (Elston, 1992;Kruglyak and Lander, 1995;Weeks et al., 1995;Kruglyak
et al., 1996). Due to computational constraints, the marker-by-marker singlepoint results are
presented only for ND and the FTND measure. Note that singlepoint and multipoint results are
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usually correlated – singlepoint-multipoint Spearman σ for ND was 0.73 and 0.74 for FTND).
A more complete discussion of singlepoint and multipoint linkage analyses is provided
elsewhere (Sullivan et al., 2003).
Figure 1 depicts the results of univariate genomewide linkage analyses of FTND and ND and
bivariate analyses of FTND-AlcSx and ND-AD in the context of all prior genomewide linkage
studies. Table 1 provides the numeric results for the top 1% of scores in any phenotype and
analytic method. All results are shown for any position that had at least one score in the top
1%.
For univariate analyses of continuous FTND scores, the maximum singlepoint NPL LOD score
was 2.11 at D22S1177 (chr22, 45.348 cM); however, as all other markers from chr22 25−65
cM had LODs < 0.5, the multipoint NPL LOD score at this position was 0.08. The maximum
multipoint NPL LOD score for the FTND score was 1.67 (singlepoint 0.29) at D3S2385 (chr3,
33.554 cM). In univariate analyses of lifetime ND, the maximum singlepoint NPL LOD score
was 2.05 at D11S903 (chr11, 60.942 cM). The multipoint ND analyses also highlighted the
region that was most significant in the ND singlepoint analyses along with a region an
additional region (chr22, 17.6−24.5 cM, peak multipoint NLP LOD of 3.02). Univariate
analyses of AlcSx and AD are presented elsewhere (Prescott et al., 2006) but the striking chr4
signal for AlcSx (multipoint LOD=4.59, P=0.0000021) is depicted in Figure 1.
For the bivariate analysis of the continuous FTND and AlcSx scores, multipoint LOD scores
substantially exceeded four in two genomic regions – a 11 cM region on chr7 (D7S2252 to
D7S691, maximum 5.06, empirical p=0.0006) and an 8 cM region on chr18 flanking D18S63
(maximum 4.48, empirical p=0.0007). Both regions did not meet the study-wide significance
level of 0.00001. Inspection of the standardized coefficients from these analyses suggested that
the linkage evidence at each of these loci came mostly from the FTND score (∼⅔) but with a
substantial contribution from AlcSx (∼⅓). For the bivariate analyses of discrete ND and AD
phenotypes, all multipoint LOD scores were <2.
Variance component analyses for quantitative phenotypes can yield biased results. First,
although there was no evidence of inflation in estimates of linkage in univariate FTND analyses
(median of all genome LOD scores was 0.0), there was evidence of upward bias in the bivariate
FTND-AlcSx analyses (median of all genome LOD scores was 0.51). Therefore, the empirical
p-values rather than the LOD scores should be used to describe our findings. Second, variance
components analyses are susceptible to influential single observations. Occasionally, a few
sibling pair can contribute the majority of linkage signal which raises the concern of artifact
(Mitchell et al., 1999). To investigate the degree to which this influenced our findings, we
conducted a sensitivity analysis by analyzing the contribution of each family to the overall
LOD scores for the bivariate FTND-AlcSx analyses. Briefly, no single family accounted for
more than 15% of the total χ2 at any position suggesting that the bivariate FTND-AlcSx
variance components findings are not due to an overly influential sibship.
Notably, the chr4 region that was positive in our prior report for AlcSx (Prescott et al., 2006)
showed no substantial signal for nicotine-related phenotypes (LODs for ND and FTND were
both negative) or when analyzed jointly with nicotine-related phenotypes (ND-AD LOD=0.05,
FTND-AlcSx LOD=0.252).
To facilitate the incorporation of these findings in meta-analyses, genomewide linkage results
are available in the online version of this report.1
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In this report, we conducted secondary data analyses for lifetime nicotine-related phenotypes
using genomewide linkage scan data (1,020 microsatellite markers) from 626 all possible
sibling pairs ascertained on the basis of lifetime alcohol dependence. There were four sets of
genomewide linkage analyses – univariate analyses of continuous FTND scores, univariate
analyses of a lifetime history of ND, bivariate analyses of FTND-AlcSx, and bivariate analyses
of ND-AD. We wish to highlight four genomic regions.
First, the most striking finding was from the bivariate FTND-AlcSx linkage analyses with an
empirical p-value of 0.0006 on chr7 from D7S2252 to D7S691. Although the most significant
findings did not meet a conservative estimate of study-wide significance (and thus could be
due to chance), sensitivity analyses did not suggest an artifactual result. We note that this
finding is congruent with those from Li et al. for average cigarettes per day in the Framingham
Heart Study population (Li et al., 2003b) and near those of Bergen et al. for smoking initiation
in the COGA sample (Bergen et al., 1999). Bioinformatic investigation of the known and
RefSeq genes in the 10 mb region from D7S2252 to D7S691 revealed no genes with clear first-
order connections to either nicotine or alcohol dependence. Identification or exclusion of any
etiologically-relevant locus in this region will require more exhaustive “fine-mapping”
genotyping in a case-control sample.
Second, there was some evidence for linkage from bivariate FTND-AlcSx analyses on chr18
(empirical p=0.0007). The chr18 peak is in the vicinity of findings from our prior linkage study
of nicotine dependence (Straub et al., 1999; Sullivan et al., 2004). Third, there may be an
additional peak for the bivariate FTND-AlcSx bivariate phenotype on distal chr5 although this
region is not near any prior finding. Although other regions had elevated LOD scores in these
bivariate analyses, we suggest cautious interpretation of isolated results. Note that we provide
our results as a Supplemental Table to facilitate inclusion in meta-analyses.
Fourth, the ND multipoint analyses suggested the importance of a a region on chr21 with a
peak NPL LOD of 3.02. This region has not been implicated in any prior study.
The other sets of univariate and bivariate analyses showed more modest findings that were at
the level that might be expected in a dense genome scan from the play of chance (Lander and
Kruglyak, 1995). Moreover, there was no striking overlap with those from other genomewide
surveys for nicotine-related phenotypes. Therefore, these additional linkage peaks are likely
to contain false positive findings along with an unknown proportion of true positive findings.
Formal meta-analyses of all extant data would be useful in attempting to delineate these
possibilities (Levinson et al., 2003).
There was no evidence that the linkage signal from univariate analysis of AlcSx on chr4 (peak
multipoint LOD 4.59 at D4S1611, p=0.0000021) (Prescott et al., 2006) was shared with
nicotine-related phenotypes in univariate or bivariate analyses suggesting that putative genetic
variation in this region is principally alcohol-related rather than influencing a broader addiction
phenotype.
These findings must be considered in light of a number of potential limitations. First, there was
no built-in replication sample and a clear lesson from the history of complex trait genetics is
that replication is essential. Second, this sample was ascertained on the basis of alcohol
dependence. Strictly speaking, positive linkage findings are for increased allele sharing
identical by descent for sibling similarity for nicotine-related phenotypes in the context of
considerable ethanol consumption and alcohol dependence. The relevance of these findings to
nicotine dependence more generally is unknown and unclear. An additional consequence is
that there was an attenuation of the correlation between alcohol and nicotine use. Third, as
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explicated in the Methods section, variance components linkage analyses required assumptions
of trait normality and ascertainment correction required assumptions about population
parameters. These are known imprecisely for our sample, and our assumptions may have
influenced our results.
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Summary of all published genomewide linkage studies of smoking-related phenotypes plus
the results from this study. The X-axis shows the autosomal location on the genome, from the
telomere of the short arm of chromosome 1 to the telomere of the long arm of chromosome 22
(bottom row) along with 303 band chromosomal staining on the second to bottom row.
Above these genomic data are plotted the singlepoint (dots) and multipoint (lines) LOD scores
from four sets of genomewide linkage from this study (“FTND univariate” through “ND-AD
bivariate”). Coloring is used to highlight LOD score values with grey for LODs <1, blue for
LODs 1−1.5, green for LODs 1.5−3, and red for LODs >3. The Y-axes vary in range but in all
instances indicate LOD score magnitude. For example, for the bivariate linkage analysis of
FTND and AlcSx symptom scores, five genomic regions have LODs >3 (chr 3, 5, 7, and 12).
Finally, the top set of results show information from the literature (“Prescott AlcSx” to
“Gelernter Ever/Never”) with citations provided in the text. The Prescott track shows the main
finding from the parent study. The remaining 11 tracks show first-stage genomewide linkage
results of smoking-related phenotypes (i.e., excluding fine-mapping or partial reports). Within
each row, the height and color of the bars are proportional to the -log10(P-value) and the width
of the bar shows the genomic location implicated by a particular sample. All genomic locations
are per the hg17 UCSC build (http://genome.ucsc.edu). The physical positions of the markers
showing the best findings in the primary samples were plotted (assuming a confidence interval
of ± 10 cM or, if mapping was uncertain, ± 10 megabases; four markers from the primary
samples did not map).
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